Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations

Published:2014-12 Issue:12 Volume:38 Page:1381-1391
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Santini Valeria,Prebet Thomas,Fenaux Pierre,Gattermann Norbert,Nilsson Lars,Pfeilstöcker Michael,Vyas Paresh,List Alan F.

Funder

Celgene

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference80 articles.

1. Myelodysplastic syndromes: diagnosis and staging;Malcovati;Cancer Control,2008

2. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol,2009

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

5. Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system;Schanz;J Clin Oncol,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low ALT, a marker of sarcopenia and frailty, is associated with shortened survival amongst myelodysplastic syndrome patients: A retrospective study;Medicine;2023-04-25

2. Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS);European Journal of Haematology;2022-02-03

3. Phase 1/2 Study Evaluating the Safety and Efficacy of DSP‐7888 Dosing Emulsion in Myelodysplastic Syndromes;Cancer Science;2021-12-21

4. Oral hypomethylating agents: beyond convenience in MDS;Hematology;2021-12-10

5. Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome;Experimental Hematology & Oncology;2021-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3